Phio Pharmaceuticals Corp.
PHIO
$1.99
-$0.10-4.79%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 129.35% | 105.07% | -36.61% | -35.89% | -58.45% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -12.63% | -57.64% | -57.45% | -45.58% | -12.39% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 113.42% | 96.20% | -38.47% | -37.14% | -56.03% |
|
|
|||||
| Total Current Assets | 113.42% | 96.20% | -38.47% | -37.14% | -56.03% |
| Net Property, Plant & Equipment | 600.00% | 100.00% | -94.87% | -99.52% | -99.61% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -50.00% |
| Total Assets | 113.39% | 96.12% | -38.72% | -38.52% | -56.93% |
|
|
|||||
| Total Accounts Payable | -29.85% | 33.44% | -61.49% | 6.36% | -47.74% |
| Total Accrued Expenses | -18.27% | -9.26% | -19.11% | -64.71% | -27.87% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -20.81% | 1.68% | -37.88% | -60.49% | -36.33% |
|
|
|||||
| Total Current Liabilities | -20.81% | 1.68% | -37.88% | -60.49% | -36.33% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -20.81% | 1.68% | -37.88% | -60.49% | -36.33% |
|
|
|||||
| Common Stock & APIC | 9.12% | 9.07% | 2.82% | 3.56% | 1.76% |
| Retained Earnings | -4.95% | -4.79% | -5.14% | -5.40% | -6.45% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 167.56% | 117.17% | -38.90% | -31.43% | -61.90% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 167.56% | 117.17% | -38.90% | -31.43% | -61.90% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 167.56% | 117.17% | -38.90% | -31.43% | -61.90% |
|
|
|||||